Clinical Trial Update: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating HR091506 tablets for gout with hyperuricemia in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• HR091506 tablets (HR091506)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gout With Hyperuricemia in Adults | Phase 3 | Status: COMPLETED